The effect of mulberry varieties on the protein patterns of the silkworm Bombyx mori L.
International Journal of Biological and Pharmaceutical Sciences Archive · 30.04.2026 · 11 (2) · 050-058
DOI: 10.53771/ijbpsa.2026.11.2.0040 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological and Pharmaceutical Sciences Archive, online erschienen am 30.04.2026. Verfasst von Rajkumar S. Bhonde.
Abstract (Originalsprache)
Four mulberry varieties— Kanva 2, Almora Local, China Peking China, and S-1096—were selected to study their effects on the protein banding patterns of fifth-instar larvae of Bombyx mori. The present results showed the level of haemolymph protein in different silkworm races PM x CSR2, CSR4 x CSR2, and CSR2 x CSR4 showed not much difference compared with each other, when fed on Kanva-2, Almora local MP and China Peking China mulberry varieties, only in S-1096 variety fed larvae was noticed less protein level as compared to other variety, it may due to poor leaf quality of S-1096. These findings suggest that although the general protein expression profile remains consistent across mulberry varieties, specific proteins are differentially expressed depending on the genotype of the host plant.
Zitieren
APA
Bhonde, R. S. (2026). The effect of mulberry varieties on the protein patterns of the silkworm Bombyx mori L. International Journal of Biological and Pharmaceutical Sciences Archive, 11(2), 050-058. https://doi.org/10.53771/ijbpsa.2026.11.2.0040
Vancouver
Bhonde RS. The effect of mulberry varieties on the protein patterns of the silkworm Bombyx mori L. International Journal of Biological and Pharmaceutical Sciences Archive. 2026;11(2):050-058. doi:10.53771/ijbpsa.2026.11.2.0040
BibTeX
@article{Bhonde2026,
author = {Bhonde, Rajkumar S.},
title = {The effect of mulberry varieties on the protein patterns of the silkworm Bombyx mori L},
journal = {International Journal of Biological and Pharmaceutical Sciences Archive},
year = {2026},
volume = {11},
number = {2},
pages = {050--058},
doi = {10.53771/ijbpsa.2026.11.2.0040}
}
EUVIMED